Peritoneal dialysis less costly for Medicare than hemodialysis
Aug 24, 2022
A convergence in the costs of intravenous dialysis drugs was seen between peritoneal dialysis and hemodialysis.
Surgery feasible soon after COVID-19 for vaccinated patients
Aug 05, 2022
No increased risk for perioperative complications was seen for fully vaccinated patients or those undergoing surgery without general anesthesia.
Heart transplant outcomes comparable in advanced age
Jun 09, 2021
Five-year mortality did not differ for adults aged ≥70 years and <70 years after adjustment for relevant confounders.
Gap between mortality in rural and urban areas has increased
Jun 08, 2021
Difference increased in age-adjusted mortality rates between large metropolitan areas, rural areas from 1999 to 2019.
New data show the power of COVID-19 vaccines
Aug 02, 2021
Data support what health experts have been saying for months: COVID-19 vaccines are highly effective at preventing serious illness and death.
Links between genetic risk, glaucoma prevalence examined
Jul 23, 2021
Polygenic variants are associated with comparable risk for developing open-angle glaucoma as that associated with the most common single-gene pathogenic variant, according to a study published online July...
Most Americans who wanted COVID-19 vaccine have already gotten one
Jun 30, 2021
Only 3% of those who have not been vaccinated said they plan to do so as soon as they can.
Guidelines updated for managing blood pressure in chronic kidney disease patients not on dialysis
Jun 22, 2021
Standardized office blood pressure measurement is preferred for management of high blood pressure, with target of <120 mm Hg for systolic blood pressure.
COVID-19 vaccination more likely with provider recommendation
Dec 16, 2021
Adults who receive a provider recommendation for COVID-19 vaccination are more likely to have received one or more doses of COVID-19 vaccine, according to research published in the Dec. 17 issue of the...
Mirtazapine does not reduce agitation in dementia patients
Nov 03, 2021
In a randomized, double-blind trial, no difference was seen in scores for agitated behaviors at 12 weeks with mirtazapine versus placebo.